CS
BMY.RT

Credit Suisse’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Credit Suisse’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,866,267
Closed -$10.3M – 4751
2020
Q4 		$10.3M Sell
14,866,267
-6,714,587
-31% -$14.3M 0.01% 1562
2020
Q3 		$48.6M Buy
21,580,854
+1,959,371
+10% +$5.6M 0.04% 619
2020
Q2 		$70.2M Buy
19,621,483
+644,297
+3% +$2.32M 0.07% 397
2020
Q1 		$72.1M Buy
18,977,186
+202,288
+1% +$666K 0.08% 300
2019
Q4 		$56.5M Buy
+18,774,898
New +$48.8M 0.05% 480

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $27.4M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return